Clinical Trial Update: Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT [Phase 2]

View source ↗

Summary

This report covers a Phase 2 trial evaluating eltrombopag with high-dose dexamethasone as first-line therapy for immune thrombocytopenia. The study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Promacta (eltrombopag)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Immune Thrombocytopenic Purpura | Phase 2 | Status: COMPLETED